Procter & Gamble Stock Performance
Procter & Gamble shares closed at $145.71, registering a modest daily gain of 0.09%, per SID market data. Over the trailing one-month period, PG has edged up 0.54%, though the three-month return reflects a decline of 3.06%, indicating recent sideways-to-negative momentum. On a twelve-month basis, the stock has returned just 1.5%, significantly underperforming broader market indices. The stock currently trades below both its 50-day moving average of $146.12 and its 200-day moving average of $149.75, according to Massive/Polygon technical data, suggesting persistent overhead resistance. The 14-day relative strength index stands at 49.1, reflecting neutral momentum with no overbought or oversold conditions. PG's beta of 0.382 confirms its historically low volatility profile relative to the broader market. Average daily trading volume stands at approximately 8.54 million shares, supporting consistent institutional liquidity across sessions.
Procter & Gamble Valuation Analysis
Procter & Gamble carries a market capitalization of approximately $328.9 billion, positioning it among the largest companies in the Consumer Defensive sector, per SID market data. The stock trades at a price-to-earnings ratio of 20.46, which reflects a premium relative to the broader market but is characteristic of large-cap consumer staples names with stable cash flows. The PEG ratio stands at 3.90, according to SEC filings, suggesting that the current earnings multiple significantly exceeds the company's forward growth rate and raising questions about growth-adjusted valuation. PG's price-to-book ratio of 6.44 reflects substantial intangible asset value associated with its global brand portfolio. The company maintains a dividend yield of 2.97%, reinforcing its appeal to income-oriented investors. This yield remains competitive within the Consumer Defensive sector and is supported by Procter & Gamble's longstanding status as a Dividend Aristocrat with decades of consecutive annual increases.
Smart Money Activity for PG
Procter & Gamble's composite smart money score stands at 48 out of 100, signaling a neutral overall positioning among sophisticated market participants, per SID market data. Institutional sentiment registers a perfect 25 out of 25, reflecting strong conviction and continued accumulation by major fund managers, according to 13F institutional filings. In contrast, the insider activity score sits at 0.0 out of 25, despite notable transaction volume — SEC Form 4 filings reveal 20 insider trades over the past 90 days, comprising 11 purchases and 9 sales. This near-even split between buys and sells contributes to the subdued insider signal. Dark pool activity scored 9.3 out of 25, indicating below-average off-exchange institutional demand. Congressional trading activity registered 14.0 out of 25, suggesting moderate but not outsized interest from lawmakers holding or transacting in PG shares. The divergence between strong institutional positioning and tepid insider sentiment creates a mixed smart money profile for the stock.
Procter & Gamble Earnings Outlook
Procter & Gamble has demonstrated consistent execution against Wall Street expectations in its most recent quarterly results. For the quarter reported on April 24, 2026, the company posted earnings per share of $1.59, exceeding the consensus estimate of $1.56 by $0.03, according to company earnings reports. The subsequent quarter reported on July 29, 2026 showed earnings of $1.43 per share against an estimate of $1.42, delivering a modest positive surprise of $0.01. Looking ahead, analysts project earnings of $1.42 per share for the period ending July 28, 2026, and $1.89 per share for the October 22, 2026 quarter, per analyst estimates. The sequential increase to $1.89 suggests expectations of meaningful earnings growth in the upcoming period. While Procter & Gamble continues to meet or slightly exceed forecasts, the narrow magnitude of recent beats indicates limited upside momentum relative to consensus projections.
Wall Street Analyst Ratings for PG
Recent analyst activity for Procter & Gamble reflects a shifting consensus, with two notable downgrades in August 2026, per Wall Street analyst reports. On August 7, 2026, Argus Research downgraded PG from Buy to Hold, marking a meaningful reduction in conviction from a long-standing coverage firm. Similarly, HSBC downgraded the stock from Buy to Hold on July 30, 2026, per SID consensus data. These downgrades were partially offset by maintained bullish ratings from other major institutions. Citigroup reiterated its Buy rating on July 30, 2026, while JP Morgan maintained its Overweight recommendation on July 16, 2026. Barclays maintained an Equal-Weight rating on July 21, 2026, reflecting a neutral stance. The pattern of recent activity suggests a growing division among analysts, with some firms reducing exposure citing valuation concerns while others maintain constructive views anchored by Procter & Gamble's defensive earnings profile and dividend consistency.